Optimize Non-Reduced CE-SDS Analysis with the SCIEX Low pH SDS Sample Buffer
Technical notes | 2019 | SCIEXInstrumentation
Capillary electrophoresis sodium dodecyl sulfate (CE-SDS) is widely used in biopharmaceutical R&D and QC to assess protein size heterogeneity, detect fragments, and support process development, ensuring safety and efficacy of therapeutic proteins.
This study evaluated the impact of sample buffer pH on fragmentation artifacts in non-reduced CE-SDS analysis of monoclonal antibody biosimilars. It compared a standard pH 9.0 buffer with a low pH 6.8 buffer to optimize robustness and improve correlation with orthogonal methods.
Monoclonal antibodies (adalimumab, infliximab, drozitumab) were prepared at 0.5 mg/mL by combining 50 μL protein solution with 5 μL 500 mM iodoacetamide and 45 μL SDS sample buffer (pH 9.0 or 6.8), followed by heating at 70°C for 5 minutes. Samples were centrifuged and injected using pressure (5 PSI, 65 seconds). Separations were carried out with 15 kV at 25°C, including capillary preconditioning and automated reagent replenishment.
Lowering the sample buffer pH from 9.0 to 6.8 increased main peak purity by 1.3–2.1% across all antibody biosimilars. Heavy-heavy-light chain fragment peaks and total fragment percentages were significantly reduced, while high molecular weight species showed slight decreases. Electropherograms at low pH exhibited sharper main peaks and fewer artifacts, indicating reduced disulfide scrambling.
Optimizing sample buffer pH is essential in non-reduced CE-SDS workflows to minimize disulfide bond scrambling and analytical artifacts. The low pH (6.8) SDS sample buffer significantly improves purity measurements and aligns results more closely with orthogonal methods, supporting robust biopharmaceutical characterization.
Capillary electrophoresis
IndustriesManufacturerSCIEX
Summary
Importance of the Topic
Capillary electrophoresis sodium dodecyl sulfate (CE-SDS) is widely used in biopharmaceutical R&D and QC to assess protein size heterogeneity, detect fragments, and support process development, ensuring safety and efficacy of therapeutic proteins.
Objectives and Study Overview
This study evaluated the impact of sample buffer pH on fragmentation artifacts in non-reduced CE-SDS analysis of monoclonal antibody biosimilars. It compared a standard pH 9.0 buffer with a low pH 6.8 buffer to optimize robustness and improve correlation with orthogonal methods.
Methodology
Monoclonal antibodies (adalimumab, infliximab, drozitumab) were prepared at 0.5 mg/mL by combining 50 μL protein solution with 5 μL 500 mM iodoacetamide and 45 μL SDS sample buffer (pH 9.0 or 6.8), followed by heating at 70°C for 5 minutes. Samples were centrifuged and injected using pressure (5 PSI, 65 seconds). Separations were carried out with 15 kV at 25°C, including capillary preconditioning and automated reagent replenishment.
Used Instrumentation
- PA 800 Plus Pharmaceutical Analysis System (SCIEX)
- 50 μm ID × 10 cm bare fused-silica capillaries
Main Results and Discussion
Lowering the sample buffer pH from 9.0 to 6.8 increased main peak purity by 1.3–2.1% across all antibody biosimilars. Heavy-heavy-light chain fragment peaks and total fragment percentages were significantly reduced, while high molecular weight species showed slight decreases. Electropherograms at low pH exhibited sharper main peaks and fewer artifacts, indicating reduced disulfide scrambling.
Benefits and Practical Applications
- Enhanced method robustness with reduced artificial fragmentation
- Improved agreement with orthogonal assays such as SEC
- Reliable quantitation of protein purity and stability for batch release
Future Trends and Potential Applications
- Application of low pH buffer approaches to diverse biotherapeutic formats
- Integration into automated, high-throughput QC workflows
- Development of novel buffer chemistries to further suppress disulfide exchange
Conclusion
Optimizing sample buffer pH is essential in non-reduced CE-SDS workflows to minimize disulfide bond scrambling and analytical artifacts. The low pH (6.8) SDS sample buffer significantly improves purity measurements and aligns results more closely with orthogonal methods, supporting robust biopharmaceutical characterization.
References
- Good D. et al., Methods in Molecular Biology, vol.276: Capillary Electrophoresis of Proteins and Peptides, Humana Press, 2019.
- Salas-Solano O. et al., Anal. Chem. 2006, 78, 6583–6594.
- Rustandi R. et al., Electrophoresis 2008, 29, 3612–3620.
- Dada O. et al., J. Pharm. Biomed. Anal. 2017, 145, 91–97.
- Zhang J. et al., J. Pharm. Biomed. Anal. 2010, 53, 1236–1243.
- Leer H., J. Immunol. Methods 2000, 234, 71–81.
- Wang S. et al., J. Pharm. Biomed. Anal. 2018, 154, 468–475.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Purity Analysis of Adeno-Associated Virus (AAV) Capsid Proteins using CE-SDS Method
2019|SCIEX|Applications
Purity Analysis of Adeno-Associated Virus (AAV) Capsid Proteins using CE-SDS Method Tingting Li, Mukesh Malik, Handy Yowanto, Sahana Mollah SCIEX, Brea, CA Introduction Adeno-associated virus (AAV) is one of the most widely used gene delivery vehicles for gene therapy because…
Key words
aav, aavsds, sdsbuffer, bufferviral, viralsample, sampleadeno, adenovirus, virusproteins, proteinsfolds, foldsexchange, exchangecapsid, capsidabsorbance, absorbancefigure, figuresalt, saltpreparation
Better Separation Resolution of New Biopharmaceutical Modalities through Fine Tuning of the Temperature with CE-SDS
2020|SCIEX|Applications
Better Separation Resolution of New Biopharmaceutical Modalities through Fine Tuning of the Temperature with CE-SDS Andras Guttman1 and Csenge Filep2 1SCIEX, Brea, CA 92130, USA; 2Horváth Csaba Memorial Laboratory of Bioseparation Sciences, University of Debrecen, Hungary Introduction New protein based…
Key words
sds, sdsnanobody, nanobodymodalities, modalitiesactivation, activationpolypeptides, polypeptidestemperature, temperaturegel, gelarrhenius, arrheniussieving, sievingcapillary, capillarypsa, psaenergy, energyelectrophoresis, electrophoresistherapeutics, therapeuticsmigration
Simplifying CE-SDS Data Processing
2018|SCIEX|Technical notes
Simplifying CE-SDS Data Processing Approach for Mitigating Product Peak Migration Time Drift Samuel Shepherd1, KieranKumar Mistry1, Whitney Lane Smith2, Nicholas Bond1, Vivian Lindo1, Sam Fox3, Jim Thorn3 1 MedImmune, Cambridge, UK 2 SCIEX, Darmstadt, Germany 3 SCIEX, Warrington, UK Introduction…
Key words
mineral, mineralgel, geloil, oilsciex, sciexsds, sdsmigration, migrationbuffer, buffervials, vialsreducing, reducingcapillary, capillaryhci, hcinist, nistassay, assayloq, loqmab
Agilent Biocolumns - Aggregate/Fragment Analysis - Application Compendium
2021|Agilent Technologies|Guides
Agilent Biocolumns Aggregate/Fragment Analysis Application Compendium Contents Background 2 Getting Started 3 How to Guide - Size Exclusion Chromatography for Biomolecule Analysis - 5991-3651EN 4 Featured Application Notes Elevate Your mAb Aggregate Analysis - 5994-2709EN 1 22 22 High-Resolution, High-Throughput…
Key words
return, returnsection, sectioncontents, contentsmau, mausec, secinsulin, insulinmin, minsize, sizeprotein, proteinmonomer, monomeradvancebio, advancebiotime, timeexclusion, exclusionaggregates, aggregatesmolecular